Kyverna Therapeutics, Inc. KYTX Current ratio

Current ratio at other companies

Bristol-Myers SquibbBMY

1.5×+0.3×

Gilead SciencesGILD

1.3×0.0×

Climb Bio, Inc.CLYM

27.9×+13.6×

Artiva Biotherapeutics, Inc.ARTV

24.2×+10.3×

Iovance Biotherapeutics, Inc.IOVA

4.3×+1.1×

Allogene TherapeuticsALLO

9.6×-0.1×

FAQ

What is Kyverna Therapeutics, Inc.'s current ratio?

Kyverna Therapeutics, Inc. (KYTX) reported current ratio of 8.1× in Q1 2026.

How has Kyverna Therapeutics, Inc.'s current ratio changed year-over-year?

Kyverna Therapeutics, Inc.'s current ratio increased by 9.5% year-over-year, from 7.4× to 8.1×.

What is the long-term trend for Kyverna Therapeutics, Inc.'s current ratio?

Over 2 years (2023 to 2025), Kyverna Therapeutics, Inc.'s current ratio has grown at a 59.3% compound annual growth rate (CAGR), from 3.1× to 7.8×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.